Table 2 The repeat biopsy results at the 12–18 months post-operation.

From: A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer

Prostate biopsy

IRE cohort (116)

Clinically significant prostate cancer

28 (24.1%)

Any grade prostate cancer

69 (59.5%)

ISUP, No. (%)

 1

41 (35.3%)

 2

15 (12.9%)

 3

4 (3.4%)

 4

5 (4.3%)

 5

4 (3.4%)

  1. ISUP International Society of Urological Pathology.
Back to article page